Results 1 to 10 of about 21,513 (220)
Aspectos y consideraciones generales en la enfermedad inflamatoria intestinal durante la pandemia por COVID-19 [PDF]
Revista de Gastroenterología de México, 2020 Resumen: Hasta este momento, la evidencia disponible sugiere que los pacientes con enfermedad inflamatoria intestinal (EII) no tienen un mayor riesgo de desarrollar COVID-19.
J.L. de León-Rendón +2 more
doaj +2 more sources
Epidemiología de la enfermedad inflamatoria intestinal
Revista Médica Clínica Las Condes, 2019 Resumen: La Enfermedad Inflamatoria Intestinal (EII) engloba principalmente a la Colitis ulcerosa (CU) y a la Enfermedad de Crohn (EC). Ambas patologías son de carácter crónico y de etiología desconocida.
Carolina Figueroa
exaly +3 more sources
Synergistic effects of vedolizumab and JAK 1,2,3 inhibitors in Crohn’s disease: insights from a systems biology and artificial intelligence-based approach [PDF]
Frontiers in ImmunologyBackground and aimsWhile current therapies for Crohn’s disease (CD), including vedolizumab (VDZ) and Janus kinase inhibitors (JAKi), have shown efficacy individually through different mechanisms of action, their combination may offer a more integrated ...
Ignacio Marín-Jiménez +6 more
doaj +2 more sources
Nutrición y enfermedad inflamatoria intestinal: posibles mecanismos en la incidencia y manejo
Revista Médica Clínica Las Condes, 2021 Resumen: La enfermedad inflamatoria intestinal (EII), cuyos fenotipos más frecuentes son la enfermedad de Crohn (EC) y la colitis ulcerosa (CU), tiene una etiología multifactorial, que resulta de la interacción de factores genéticos, ambientales y del ...
María José Escaffi +3 more
doaj +1 more source
Veterinary Dermatology, Volume 32, Issue 4, Page 331-e92, August 2021., 2021 Background MicroRNAs (miRNA) are short, single‐stranded RNA molecules that regulate gene expression in a post‐transcriptional manner. Their expression is proposed to be tissue‐specific and alterations in miRNA expression have been detected in many diseases. Objective To compare miRNA expression in the skin of healthy Labrador and golden retrievers, and
Marie Isabel Morlang +3 more
wiley +1 more source
Gut dysbiosis and clinical phases of pancolitis in patients with ulcerative colitis
MicrobiologyOpen, Volume 10, Issue 2, April 2021., 2021 The purpose of this study was to evaluate whether gut microbiota is related to the active and remission phases of pancolitis in patients with ulcerative colitis, as well as in healthy participants. Abstract Ulcerative colitis (UC) is a frequent type of inflammatory bowel disease, characterized by periods of remission and exacerbation. Gut dysbiosis may
Brenda Maldonado‐Arriaga +12 more
wiley +1 more source
Aspects of inflammatory bowel disease during the COVID-19 pandemic and general considerations
Revista de Gastroenterología de México (English Edition), 2020 So far, available evidence suggests that patients with inflammatory bowel disease (IBD) are not at greater risk for developing COVID-19 infection.
J.L. de León-Rendón +2 more
doaj +1 more source
Revista de Gastroenterología de México (English Edition), 2022 Introduction and aims: The 5-aminosalicylates, especially mesalazine, are the first option in the treatment of mild-to-moderate ulcerative colitis (UC).
J.K. Yamamoto-Furusho +1 more
doaj +1 more source
Revista Médica Clínica Las Condes, 2019 RESUMEN: La escasez de investigación en Chile nos hace depender de manera excesiva de los resultados de la investigación foránea, los cuales no siempre son aplicables a la realidad nacional.
Rodrigo Quera +7 more
doaj +1 more source
Revista de Gastroenterología de México, 2022 Resumen: Introducción y objetivos: Los 5-aminosalicilatos, principalmente la mesalazina, es la primera opción de tratamiento para la colitis ulcerosa crónica idiopática (CUCI) con actividad de leve a moderada.
J.K. Yamamoto-Furusho +1 more
doaj +1 more source